Mutation-specific Therapy for the Long QT Syndrome

Condition:   Long QT Syndrome Intervention:   Drug: Lumacaftor / Ivacaftor, Orkambi® Oral Tablet Sponsor:   Istituto Auxologico Italiano Not yet recruiting

Source: ClinicalTrials.gov - October 9, 2020 Category: Research Source Type: clinical trials